Clinical Trial Update: A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating the safety and efficacy of bone marrow derived autologous cells for autism in Phase 1/Phase 2. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• bone marrow derived autologous cells

Snippet

Sponsor: Chaitanya Hospital, Pune | Conditions: Autism | Phase 1, Phase 2 | Status: UNKNOWN